Baxter International Inc (BAX.N)

BAX.N on New York Stock Exchange

76.59USD
11 Jul 2014
Price Change (% chg)

$-0.16 (-0.21%)
Prev Close
$76.75
Open
$76.56
Day's High
$76.65
Day's Low
$76.10
Volume
441,021
Avg. Vol
633,115
52-wk High
$76.78
52-wk Low
$62.80

BAX.N

Chart for BAX.N

About

Baxter International Inc. (Baxter) is a global, diversified healthcare company. Baxter, through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions.... (more)

Overall

Beta: 0.71
Market Cap (Mil.): $41,557.73
Shares Outstanding (Mil.): 542.60
Dividend: 0.52
Yield (%): 2.72

Financials

  BAX.N Industry Sector
P/E (TTM): 20.80 29.89 35.77
EPS (TTM): 3.68 -- --
ROI: 11.49 9.72 18.27
ROE: 25.79 11.50 19.16
Search Stocks

UPDATE 1-Medtronic's Covidien deal raises bar for rivals to merge

(Rewrites with analyst, fund manager comment on potential future deals)

16 Jun 2014

U.S. justices decline to hear dialysis machine patent case

WASHINGTON - The U.S. Supreme Court declined on Monday to hear an appeal filed by healthcare company Baxter International Inc over a patent dispute with rival Fresenius Medical Care AG & Co.

19 May 2014

U.S. justices decline to hear dialysis machine patent case

WASHINGTON, May 19 - The U.S. Supreme Court declined on Monday to hear an appeal filed by healthcare company Baxter International Inc over a patent dispute with rival Fresenius Medical Care AG & Co.

19 May 2014

DIARY-U.S. MEETINGS/WEEK AHEAD

THOMSON REUTERS, May 06,2014 - Corporate Meetings for US companies for Week ahead. S&P 500 Earnings - Weekly S&P 500 Earnings - Day Ahead Non S&P 500 - Weekly Non S&P 500 - Day Ahead ConferenceCall/Webcast - Weekly ConferenceCall/Webcast - Day S&P 500 Earnings - Monthly Meetings - Day Ahead Economic Indicators Dividends Daily earnings hits & misses Federal Rese

06 May 2014

DIARY-U.S. MEETINGS/WEEK AHEAD

THOMSON REUTERS, May 05,2014 - Corporate Meetings for US companies for Week ahead. S&P 500 Earnings - Weekly S&P 500 Earnings - Day Ahead Non S&P 500 - Weekly Non S&P 500 - Day Ahead ConferenceCall/Webcast - Weekly ConferenceCall/Webcast - Day S&P 500 Earnings - Monthly Meetings - Day Ahead Economic Indicators Dividends Daily earnings hits & misses Federal Rese

05 May 2014

DIARY-U.S. MEETINGS/WEEK AHEAD

THOMSON REUTERS, May 02,2014 - Corporate Meetings for US companies for Week ahead. S&P 500 Earnings - Weekly S&P 500 Earnings - Day Ahead Non S&P 500 - Weekly Non S&P 500 - Day Ahead ConferenceCall/Webcast - Weekly ConferenceCall/Webcast - Day S&P 500 Earnings - Monthly Meetings - Day Ahead Economic Indicators Dividends Daily earnings hits & misses Federal Rese

02 May 2014

DIARY-U.S. MEETINGS/WEEK AHEAD

THOMSON REUTERS, May 01,2014 - Corporate Meetings for US companies for Week ahead. S&P 500 Earnings - Weekly S&P 500 Earnings - Day Ahead Non S&P 500 - Weekly Non S&P 500 - Day Ahead ConferenceCall/Webcast - Weekly ConferenceCall/Webcast - Day S&P 500 Earnings - Monthly Meetings - Day Ahead Economic Indicators Dividends Daily earnings hits & misses Federal Rese

01 May 2014

DIARY-U.S. MEETINGS/WEEK AHEAD

THOMSON REUTERS, Apr 30,2014 - Corporate Meetings for US companies for Week ahead. S&P 500 Earnings - Weekly S&P 500 Earnings - Day Ahead Non S&P 500 - Weekly Non S&P 500 - Day Ahead ConferenceCall/Webcast - Weekly ConferenceCall/Webcast - Day S&P 500 Earnings - Monthly Meetings - Day Ahead Economic Indicators Dividends Daily earnings hits & misses Federal Rese

30 Apr 2014

U.S. FDA approves Biogen's hemophilia B drug Alprolix

- Biogen Idec Inc has won U.S. approval for its long-acting hemophilia B treatment Alprolix, the U.S. Food and Drug Administration said on Friday.

28 Mar 2014

UPDATE 1-U.S. FDA approves Biogen's hemophilia B drug Alprolix

March 28 - Biogen Idec Inc has won U.S. approval for its long-acting hemophilia B treatment Alprolix, the U.S. Food and Drug Administration said on Friday.

28 Mar 2014

Competitors

  Price Change
Johnson & Johnson (JNJ.N) $105.10 -0.70
Pfizer Inc. (PFE.N) $30.07 +0.07
Roche Holding Ltd. (ROG.VX) CHF262.70 +0.50
Abbott Laboratories (ABT.N) $41.30 +0.28
Boston Scientific Corporation (BSX.N) $13.29 +0.19
Wyeth Limited (WLED.NS) Rs925.90 +4.35
Hospira, Inc. (HSP.N) $50.82 -0.24

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00
Provider: Stock Traders Daily
$20.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks